Novel high molecular weight albumin-conjugated angiotensin II activates β-arrestin and G-protein pathways

  • Hong Weng Pang
  • , Andrea Linares
  • , Leena Couling
  • , Jessica Santollo
  • , Leonardo Ancheta
  • , Derek Daniels
  • , Robert Charles Speth

Research output: Contribution to journalArticlepeer-review

Abstract

PURPOSE: To study the ability of a novel bovine serum albumin-angiotensin II (BSA-Ang II) conjugate to effect responses of the AT

METHODS: Angiotensin II (Ang II) was conjugated with bovine serum albumin and compared with Ang II for competition binding to AT

RESULTS: The BSA-Ang II conjugate was less potent competing for AT

CONCLUSIONS: Addition of a high molecular weight molecule to Ang II reduced its AT

Original languageAmerican English
JournalEndocrine
Volume66
DOIs
StatePublished - Nov 1 2019

Keywords

  • AT1 receptor; Aldosterone release; Biased agonism; Bovine serum albumin-conjugated angiotensin II; Calcium mobilization; Salt appetite

Disciplines

  • Medicine and Health Sciences
  • Pharmacy and Pharmaceutical Sciences

Fingerprint

Dive into the research topics of 'Novel high molecular weight albumin-conjugated angiotensin II activates β-arrestin and G-protein pathways'. Together they form a unique fingerprint.

Cite this